-
Loading metrics
Adverse events analysis of Relugolix (Orgovyx®) for prostate cancer based on the FDA Adverse Event Reporting System (FAERS)
- Ruibo Li,
- Xi Chen,
- Yujie Wang
x
- Published: October 22, 2024
- https://doi.org/10.1371/journal.pone.0312481